PVLA Palvella Therapeutics, Inc.

NASDAQ
$145.77

Palvella Therapeutics, Inc. (PVLA) Earnings News

Earnings press releases, previews and reviews for Palvella Therapeutics, Inc. (PVLA), newest first. Our most recent is review: Palvella's Narrow Miss Is a Sideshow: Priority Review Sets a February 2027 Verdict as Launch Spending Accelerates.